EBH 38 Advancements in ALS: Cutting-Edge Treatments and Emerging Biotech Innovations

Discover the latest advancements in the fight against Amyotrophic Lateral Sclerosis (ALS), a devastating neurodegenerative disease. In this video, we delve into cutting-edge treatments and emerging biotech innovations that are offering new hope for patients and their families.

EBH 38 Advancements in ALS: Cutting-Edge Treatments and Emerging Biotech Innovations Read More »

EBH 37 Advancements in Alzheimer’s Disease: Current Trends and Future Directions

Learn about new and emerging treatments for Alzheimer’s, including drug therapies targeting amyloid and tau, immunotherapies, and combination therapies. Explore how cutting-edge biotechnologies, such as gene therapy, stem cell research, and CRISPR, are being utilized to develop novel treatments for Alzheimer’s.

EBH 37 Advancements in Alzheimer’s Disease: Current Trends and Future Directions Read More »

EBH 36 Advances in Parkinson’s Disease: Understanding, Treatment, and Emerging Biotechnologies

Join us as we delve into the latest advances in the understanding and treatment of Parkinson’s disease, a complex and progressive neurological disorder. In this video, we’ll explore groundbreaking research, innovative treatments, and emerging biotechnologies that are offering new hope to patients and their families.

EBH 36 Advances in Parkinson’s Disease: Understanding, Treatment, and Emerging Biotechnologies Read More »

EBH 35 Brain Disorders

Join us as we explore the forefront of brain disorder research and treatment, uncovering the trends and innovations that are set to transform brain health. Discover the latest scientific breakthroughs in brain research, including advancements in neuroimaging, biomarkers, and genetic research.Learn about novel therapeutic approaches, such as gene therapy, neurostimulation, and personalized medicine.

EBH 35 Brain Disorders Read More »

Long-Term Strategy for Investing in Biotech​

At Evergrowth, we agree with Warren Buffett that patience pays off when it comes to investment. We have no interest in passing market trends or quick profits. Rather, we concentrate on keeping investments for the long term, letting them grow and realize their full potential.​​For you, that entails the following:​ Our long-term strategy basically seeks to accomplish

Long-Term Strategy for Investing in Biotech​ Read More »

EBH 34 Mental Health Innovation: Emerging Trends and Investment Horizons

Discover the latest trends in mental health care, the integration of mental health services into primary care, and the growing emphasis on holistic and preventive approaches. Explore how digital health tools, including mental health apps, virtual reality, and AI, are transforming patient care and support.

EBH 34 Mental Health Innovation: Emerging Trends and Investment Horizons Read More »

Dr. Harvey Tran’s Investment Philosophy​

Dr. Harvey Tran, Tran, the mastermind behind the Evergrowth BioHealthcare Capital fund, is a highly-skilled, savvy in the biotechnology industry inancial professional.. His investment philosophy, characterized by a unique blend of expertise and intuition, has been instrumental in the fund’s success. The core principles that guide Dr. Tran’s investment decisions are​: By combining his experience,

Dr. Harvey Tran’s Investment Philosophy​ Read More »

EBH 33 Revolutionizing Cholesterol Management: Trends, Innovations, and Investment Horizons

Join us as we explore the forefront of cholesterol management, uncovering how these trends and innovations are set to improve health outcomes and create new opportunities for investment. Discover the latest advancements in cholesterol-lowering therapies, including new medications, gene editing technologies, and lifestyle interventions.

EBH 33 Revolutionizing Cholesterol Management: Trends, Innovations, and Investment Horizons Read More »

What is Integrated Bioscience Research?

It combines investing accuracy with drug discovery.​Integrated bioscience research utilizes ideas from other domains to improve investment precision and uncover alpha intelligence for drug discovery. ​​The idea of integrated investment is admitting our limits. Physicians may lack financial analytic abilities; financiers may not understand medical complexities; and scientists may be unfamiliar with prescription trends. To

What is Integrated Bioscience Research? Read More »